LEVIN JEREMY M has filed 15 insider transactions across 1 company since September 2019.
Most recent transaction: a option exercise of 47333 shares of Ovid Therapeutics Inc. ($OVID) on March 23, 2026.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | Executive Chairman | M | Common Stock | 47333 | $1.40 | 3,770,509.0000 | 71,212,353 | 1.27% | 0.07% |
| March 23, 2026 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | Executive Chairman | M | Series A Warrant (right to buy) | 47333 | $0.00 | 0.0000 | 71,212,353 | 100.00% | 0.07% |
| Feb. 26, 2026 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | Not found | A | Employee Stock Option (Right to Buy) | 957000 | $0.00 | 957,000.0000 | 71,212,353 | 9999.99% | 1.34% |
| Dec. 15, 2025 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | C | Common Stock | 71000 | $0.00 | 3,723,176.0000 | 71,212,353 | 1.94% | 0.10% |
| Dec. 11, 2025 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | P | Series B Convertible Preferred Stock | 71 | $0.00 | 71.0000 | 71,212,353 | 9999.99% | 0.00% |
| Dec. 11, 2025 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | P | Series A Warrant (right to buy) | 47333 | $0.00 | 47,333.0000 | 71,212,353 | 9999.99% | 0.07% |
| Dec. 15, 2025 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | C | Series B Convertible Preferred Stock | 71 | $0.00 | 0.0000 | 71,212,353 | 100.00% | 0.00% |
| Dec. 11, 2025 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | P | Series B Warrant (right to buy) | 35500 | $0.00 | 35,500.0000 | 71,212,353 | 9999.99% | 0.05% |
| Feb. 20, 2025 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | A | Employee Stock Option (Right to Buy) | 1650000 | $0.00 | 1,650,000.0000 | 0 | 9999.99% | 0.00% |
| March 18, 2024 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | P | Common Stock | 18248 | $2.76 | 3,652,176.0000 | 0 | 0.50% | 0.00% |
| Feb. 22, 2024 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | A | Stock Option (Right to Buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 20, 2019 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | G | Common Stock | 465116 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 4, 2023 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | G | Common Stock | 573275 | $0.00 | 3,633,928.0000 | 0 | 13.63% | 0.00% |
| Dec. 4, 2023 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | G | Common Stock | 573275 | $0.00 | 4,207,203.0000 | 0 | 11.99% | 0.00% |
| Feb. 23, 2023 | Ovid Therapeutics Inc. | $OVID | LEVIN JEREMY M | CEO | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |